semaglutide compounding news november 2025 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Despite FDA ruling, compounded GLP-1s

Tennessee, 2013: Twenty-six patients suffered from bacterial and fungal infections in the skin and soft tissue after receiving contaminated steroid injections made by a compounding pharmacy

GLP-1RAs are frequently used in the treatment of type 2 diabetes

1,2 Endogenous GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), which results in a short half-life of approximately 1 to 2 minutes

Some research has found associations between oral berberine supplementation and changes in certain metabolic markers in specific study populations, particularly those with existing metabolic concerns

We have worked with some of the worlds leading life sciences players on their most significant reputational or commercial challenges

And the broader regulatory uncertainty around compounded semaglutide applies to Direct Meds as much as any other platform